MEDLAB Middle East 2021 Brings World of Laboratory Medicine Together Under ‘United by Business’ Show Theme
|
By LabMedica International staff writers Posted on 21 Jun 2021 |

Illustration
The 2021 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, took place at the Dubai World Trade Centre from 21-24 June, bringing the global healthcare community together under the show theme of ‘United by Business’.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.
Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.
Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.
These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.
Latest MEDLAB 2021 News
- Ortho Exhibits VITROS Range of Diagnostic Testing and Automation Solutions at MEDLAB Middle East 2021
- MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021
- BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021
- Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021
- Randox Showcases Latest Product Portfolio and Services at MEDLAB Middle East 2021
- Horiba Medical Exhibits New Generation of Automated Hematology Analyzers at MEDLAB Middle East 2021
- Rad Source Technologies Introduces Premier X-Ray Blood Irradiator RS 3400 at MEDLAB Middle East 2021
- Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021
- Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021
- Bioperfectus Presents Advanced Infectious Disease Diagnostic Solutions at MEDLAB Middle East 2021
- PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021
- PerkinElmer’s EUROIMMUN Presents Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
- LumiraDx Highlights Next-Generation Point of Care Solutions at MEDLAB Middle East Virtual Event
- Quidel Showcases Comprehensive Suite of COVID-19 Testing Solutions at MEDLAB Middle East 2021
Channels
Clinical Chemistry
view channel
Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more
Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis
Cancer cells require large amounts of nutrients to grow and proliferate, and amino acids support key processes including protein formation, energy production, and DNA synthesis. Colorectal cancer is marked... Read moreMolecular Diagnostics
view channel
Blood Gene Expression Fluctuates More Than Expected Over Time
Blood-based gene expression is widely used to explore disease biology, but temporal variability can complicate interpretation of single time-point measurements. Seasonal shifts, time of day, and subclinical... Read more
Genomic Test Helps Early Breast Cancer Patients Avoid Chemotherapy
Adjuvant chemotherapy decisions in early breast cancer can expose many patients to toxicities without clear benefit when clinical factors alone do not precisely predict recurrence risk. Clinicians therefore... Read more
Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay
Merkel cell carcinoma is a rare, aggressive skin cancer with a substantial risk of relapse, occurring in about 40% of patients. Surveillance remains challenging because widely used serologic monitoring... Read moreHematology
view channel
Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
imal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately 202,000... Read more
New Marker Helps Detect Aggressive Multiple Myeloma Earlier
Multiple myeloma is an incurable malignancy of plasma cells and the second most common blood cancer worldwide, with more than 188,000 new cases each year. Although therapies have advanced, most patients... Read moreImmunology
view channel
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read moreMicrobiology
view channel
Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance
Drug-resistant Neisseria gonorrhoeae is straining current treatment protocols and elevating the risk of complications across sexual health services. More than 500,000 cases are reported each year in the... Read more
New Rapid Ebola Antigen Test Detects Infection at Point of Care
A serious Ebola epidemic centered in the Democratic Republic of the Congo has caused hundreds of deaths and triggered a global public health emergency, with cases also reported in Uganda.... Read more
Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
U.S. health authorities have reported a rapid increase in cyclosporiasis since May 2026, with more than 1,600 confirmed infections and thousands of additional suspected cases under investigation.... Read more
Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
Bloodstream infections require rapid identification of causative pathogens and resistance mechanisms to guide effective therapy. Delays in profiling gram-negative organisms, which are frequently associated... Read morePathology
view channel
AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer
Breast cancer diagnostic workflows increasingly depend on accurate quantification of immunohistochemical biomarkers to guide therapy selection, yet manual scoring can be variable and time-consuming.... Read more
Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response
Breast cancer prognosis often depends on microscopic assessment of tumor architecture, a process that can be subjective and lead to variable predictions across patient groups. Quantitative measures that... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
NanoSomiX, Inc. and Beckman Coulter Diagnostics announced a collaboration to explore the development of next-generation immunoassays for neurodegenerative diseases using extracellular vesicles (EVs).... Read more









